Oddo BHF - RENK GROUP AG (R3NK) RENK : Neutre vs Surperformance – une valorisation tendue pour un profil de croissance légèrement inférieur à certains pairs

Report

Oddo BHF

Olfa Taamallah ...

Yan Derocles

RENK : Neutre vs Surperformance – une valorisation tendue pour un profil de croissance légèrement inférieur à certains pairs

>Forte visibilité et prises de commandes dynamiques - Renk dispose déjà d’une forte visibilité avec un carnet de commandes (y compris frame et soft) offrant l’équivalent de 5 années de CA, mais nous pensons que la dynamique ne faiblira pas dans les prochains mois avec l’anticipation d’un book-to-bill supérieur à 1.4x en FY 24, fortement tiré par VMS. De nombreux appels d’offre sont en effet en cours dans la défense avec notamment l’Italie (programme A2CS pour les véhi...

05/04/2024 1 FR

Underlying

RENK GROUP AG

See profile

DE000RENK730 Germany

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Olfa Taamallah

Yan Derocles

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 04/05/2024

...

April 5, 2024 April 5, 2024 1 EN

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 05/04/2024

...

April 5, 2024 April 5, 2024 1 FR

Oddo BHF

RENK : Neutral vs Outperform – a strained valuation for a slightly weaker growth profile than at some peers

>Strong visibility and momentum in order intake - RENK already has strong visibility with an order book (including frame and soft) offering the equivalent of 5 years of sales, but we think that the momentum is unlikely to waver in the coming months with the expectation of a book-to-bill above 1.4x in FY 2024, driven sharply by VMS. Many tender bids are underway in defence, notably for Italy (A2CS programme for infantry vehicles and tank purchases), the Czech Republic ...

April 5, 2024 April 5, 2024 1 EN

Ørsted : Good performance in offshore encouraging

>Results a shade below forecasts but a positive performance in offshore - EBITDA Q1 2024 was DKK 7,488m (+8%) vs DKK 7,700m estimated (ODDO BHF and consensus) and EBIT was DKK 5,065m (+13%) vs DKK 5,200m (ODDO BHF) and DKK 5,400m (consensus). Adjusted net income was below forecasts at DKK 2,609m (-19%) vs ODDO BHF and the consensus at DKK c.3,400m. The reason for the difference in net income was due to the recognition of a deferred tax liability related to an initial...

1h / 25m 1h / 25m 1 FR

Klaus Breitenbach

Klaus Breitenbach

Leifheit AG : Making life at home easier and more convenient

Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to ...

1h / 25m 1h / 25m 1 EN

Damien Choplain ... (+2)

Damien Choplain
Martial Descoutures

Novo Nordisk : Diabetes franchise leading the way

>Insulin business in the spotlight - Novo Nordisk’s Q1 2024 results, reported this morning, beat expectations for revenues and margins: +2% ahead of expectations for the top line (DKK 65.5bn, +24% cc) and 9% better for EBIT (DKK 31.9bn, +30% cc). The GLP-1 franchise, driven by Ozempic (+65% cc), is keeping up the pace, with an increase in market share in its diabetes franchise and positive volume momentum (6% growth in GLP-1 prescriptions). But this release was m...

1h / 31m 1h / 31m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

RENK : Neutre vs Surperformance – une valorisation tendue pour un profil de croissance légèrement inférieur à certains pairs

ODDO BHF Small & MIDCAP MORNING NEWS - 04/05/2024

ODDO BHF Small & MIDCAP MORNING NEWS - 05/04/2024

RENK : Neutral vs Outperform – a strained valuation for a slightly weaker growth profile than at some peers

Ørsted : Good performance in offshore encouraging

Leifheit AG : Making life at home easier and more convenient

Novo Nordisk : Diabetes franchise leading the way

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe